Novartis India Limited
Background and Context
The Company had issued the original Notice for its 78th AGM on August 27, 2026, scheduled to be held on Thursday, September 24, 2026, at 11:00 AM IST through Video Conferencing/Other Audio-Visual Means. The Notice along with the Annual Report for FY 2025-26 was circulated to members on September 2, 2026.
Corrections and Omissions
A corrigendum has been issued to address two specific omissions in the original AGM Notice:
1. Agenda Item No. 9 (Employee Stock Option Scheme 2026): Certain disclosures required under Rule 12 of the Companies (Share Capital and Debentures) Rules, 2014 and SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 were inadvertently omitted from the Explanatory Statement.
2. Agenda Item No. 8 (Annexure 2, Page 50): The nature of industry of the Company was inadvertently omitted and should be read as "Pharmaceutical Industry".
Corrective Actions Taken
The Company has included a comprehensive and updated Explanatory Statement containing all requisite disclosures as Annexure 1 to the Corrigendum. Shareholders are requested to read this revised Explanatory Statement in conjunction with the original AGM Notice when considering and voting on Agenda Items 8 and 9.
Distribution and Availability
The Corrigendum to the AGM Notice was circulated on September 18, 2026, through electronic mode to members whose email addresses are registered with the Company/Depository Participants. The document is also available on the Company's website at https://nilpharma.co.in/annual-general-meeting/.